中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [10]
中国科学院大学 [6]
化学研究所 [4]
数学与系统科学研究院 [4]
自动化研究所 [2]
武汉岩土力学研究所 [2]
更多
采集方式
OAI收割 [25]
iSwitch采集 [6]
内容类型
期刊论文 [30]
会议论文 [1]
发表日期
2022 [2]
2021 [3]
2020 [1]
2019 [4]
2018 [6]
2017 [1]
更多
学科主题
筛选
浏览/检索结果:
共31条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
Measuring early-stage attentional bias towards food images using saccade trajectory deviations
期刊论文
OAI收割
CURRENT PSYCHOLOGY, 2022, 页码: 13
作者:
Chen, Qin
;
Peng, Shisang
;
Luo, Changlin
;
Zhuang, Xiangling
;
Ma, Guojie
  |  
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2022/12/21
Restrained eaters
Saccade curvature
Attentional bias
Goal conflict
Trastuzumab in combination with PEGylated interferon-alpha 1b exerts synergistic antitumor activity through enhanced inhibition of HER2 downstream signaling and antibody-dependent cellular cytotoxicity
期刊论文
OAI收割
AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 卷号: 12, 期号: 2, 页码: 549-561
作者:
Xu, Piaopiao
;
Chen, Xiangling
;
Xu, Yongping
;
Fu, Li
;
Li, Yun
  |  
收藏
  |  
浏览/下载:52/0
  |  
提交时间:2022/06/15
Trastuzumab
PEGylated IFN-alpha 1b
ADCC
HER2-positive cancer
synergistic effect
Preclinical characterization of LOXO-338, a novel, oral and selective BCL2 inhibitor.
期刊论文
OAI收割
CANCER RESEARCH, 2021, 卷号: 81, 期号: 13, 页码: 1
作者:
Brandhuber, Barbara
;
Ku, Karin
;
Lallena, Maria J.
;
Baquero, Carmen
;
Choy, Regina
  |  
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2021/11/04
Quantitative proteomics reveals Shexiang Baoxin Pill exerts cardioprotective effects by preserving energy metabolism in a rat model of myocardial infarction
期刊论文
OAI收割
JOURNAL OF ETHNOPHARMACOLOGY, 2021, 卷号: 266, 页码: 10
作者:
Yu, Feng
;
Yu, Yue
;
Tian, Saisai
;
Zhou, Yanting
;
Chen, Xiangling
  |  
收藏
  |  
浏览/下载:53/0
  |  
提交时间:2021/05/24
Shexiang baoxin pill
Cardiovascular disease
LC-MS/MS
Quantitative proteomics
Energy metabolism
CHAOS CONTROL IN A SPECIAL PENDULUM SYSTEM FOR ULTRA-SUBHARMONIC RESONANCE
期刊论文
OAI收割
DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES B, 2021, 卷号: 26, 期号: 2, 页码: 847-860
作者:
Chen, Xianwei
;
Fu, Xiangling
;
Jing, Zhujun
  |  
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2021/04/26
Pendulum equation
homoclinic chaos
heteroclinic chaos
chaos control
Melnikov methods
Clinical-Coder: Assigning Interpretable ICD-10 Codes to Chinese Clinical Notes
会议论文
OAI收割
Online, July 5 - 10, 2020
作者:
Pengfei Cao
;
Chenwei Yan
;
Xiangling Fu
;
Yubo Chen
;
Kang Liu
  |  
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2023/06/26
Uncovering kappa-opioid receptor agonist-induced PAK1/2 phosphorylation by quantitative phosphoproteomics
期刊论文
OAI收割
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 卷号: 516, 期号: 1, 页码: 320-326
作者:
Wu, Jianhong
;
Jiang, Qinghui
;
Zhu, Hongwen
;
Zhou, Yanting
;
Lu, Dayun
  |  
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2020/07/01
Dimethyl labeling
Kappa-opioid receptor
Kinase-substrate network
p21-activated kinases
Quantitative phosphoproteomics
Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics
期刊论文
OAI收割
JOURNAL OF PROTEOME RESEARCH, 2019, 卷号: 18, 期号: 6, 页码: 2654-2665
作者:
Chen, Xiangling
;
Lu, Dayun
;
Gao, Jing
;
Zhu, Hongwen
;
Zhou, Yanting
  |  
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2020/07/01
deubiquitinase
USP9X
NFX1-123
SILAC
quantitative proteomics
Microwave Responsive Nanoplatform via P-Selectin Mediated Drug Delivery for Treatment of Hepatocellular Carcinoma with Distant Metastasis
期刊论文
OAI收割
NANO LETTERS, 2019, 卷号: 19, 期号: 5, 页码: 2914-2927
作者:
Xu, Jinshun
;
Chen, Xueqing
;
Tan, Longfei
;
Fu, Changhui
;
Ahmed, Muneeb
  |  
收藏
  |  
浏览/下载:72/0
  |  
提交时间:2019/07/11
Nanoplatform
P-selectin
microwave
hepatocellular carcinoma
metastasis
Design, Synthesis and Pharmacological Evaluation of Novel Hsp90N-terminal Inhibitors Without Induction of Heat Shock Response
期刊论文
OAI收割
CHEMISTRYOPEN, 2019, 卷号: 8, 期号: 3, 页码: 344-353
作者:
Liu, Peng
;
Chen, Xiangling
;
Zhu, Jianming
;
Li, Bo
;
Chen, Zhaoqiang
  |  
收藏
  |  
浏览/下载:46/0
  |  
提交时间:2020/07/01
autophagy
Hsp72
Hsp90 inhibitor
triazines
antitumor activity